SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-24-000049
Filing Date
2024-06-03
Accepted
2024-06-03 16:35:21
Documents
1
Period of Report
2024-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4694
  Complete submission text file 0001235802-24-000049.txt   6252
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Issuer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address TWO CARLSON PARKWAY, SUITE 260 MINNEAPOLIS MN 55447
Business Address
Semba Charles Pauling (Reporting) CIK: 0001872863 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 241014223